Provider networks as an affordability strategy, not only an access rule

Provider networks are often treated as a rule about access — a list of who is in and who is out, managed to keep members inside an approved set of providers. That framing is not wrong, but it is small. It reduces one of the most powerful affordability tools a funder has to an administrative constraint, and it explains why so many networks deliver less than they promised.

A network is not primarily a restriction. It is a mechanism for buying care at a price and quality a product can sustain. When it is designed as an affordability strategy — with cost, quality and access weighed together — it changes what a product can offer at a given contribution. When it is designed only as an access rule, it becomes a source of member friction that produces discounts on paper and little in the claims.

The discount illusion

The most common way a network under-delivers is subtle. The funder negotiates favourable tariffs, signs the agreements and books the expected saving. The benefit design, however, does not meaningfully route members through the network. Members can go elsewhere without much consequence, so many of them do. The negotiated tariff applies to a fraction of the volume, and the saving that appeared in the business case never fully materialises.

The network was real. The affordability strategy was not, because the network was never connected to the benefit design that would drive volume through it. A network only creates value at the point where a member actually uses it, and that point is governed by product design, not by the provider agreement.

Affordability is a trade-off, not a discount

Treating a network as an affordability strategy means being explicit about the trade-off at its centre: cost, quality and access cannot all be maximised at once, and pretending otherwise produces networks that satisfy none of them.

A narrow, tightly managed network can buy care at a lower price, but it asks more of members in convenience and choice, and it concentrates risk if a key provider exits. A broad, open network protects access and member satisfaction but surrenders most of the funder's negotiating leverage. Neither is right in the abstract. The right design depends on the product, the segment and the price point it has to hit.

This is why network design cannot be delegated to a procurement exercise focused on tariff alone. The cheapest network is not the most affordable one if it drives members away or fails on quality in ways that generate downstream cost. Affordability is the whole trade-off, held together deliberately, not the lowest line on a tariff schedule.

The information asymmetry underneath it

There is a structural feature of funder–provider relationships that shapes every network discussion, and it is worth naming plainly. Funders usually hold more complete claims and utilisation data than the providers they contract with. They can see patterns across the whole population that an individual provider cannot see in their own practice.

That asymmetry is not inherently a problem, but it is a fact that a good network strategy accounts for. For funders, it is a source of leverage that should be used to design better networks, not merely to win tariff negotiations. For providers, it is a gap to close — strengthening their own analytical position so that tariff and contracting discussions rest on evidence rather than on who holds the data. We work on both sides of this, and the healthier outcome is almost always one where both parties negotiate from evidence rather than from asymmetry.

Designing a network as an affordability lever

A network designed for affordability is built from the product outward, not the tariff inward.

It begins with the product and the price point it must sustain, because that defines how much the network has to contribute. It selects providers on cost and quality and efficiency together — benchmarking performance, reviewing clinical efficiency, profiling billing patterns — rather than on tariff alone. It connects the network to the benefit design so that members are actively routed through it, turning the negotiated tariff into a realised saving. It builds referral pathways so that care moves through the network coherently rather than leaking at every step. And it monitors provider performance over time, so the network stays an asset rather than decaying into a list nobody maintains.

Alternative reimbursement models extend the same logic. Fixed fees, per diems, capitation and bundled payments each shift the balance of cost predictability and provider risk differently, and each suits a different clinical context. Matching the model to the setting — discrete services, inpatient care, defined populations, episodes of care — is how a network moves from controlling price to shaping the economics of care.

The shift in framing

For a board, the reframing is straightforward but consequential. A network measured only by how well it restricts access will always look like a source of member complaints and marginal savings. A network measured by its contribution to affordability — what it lets the product offer at a sustainable price — looks like what it is: a central lever of product economics.

The funders that get the most from their networks are the ones that stopped asking "how do we keep members in network?" and started asking "what does this network let us afford?" The first question manages a rule. The second designs a strategy.